Edgewise Therapeutics, Inc. (EWTX)

34.43 +1.31 (+3.96%) USD  |  NASDAQ  |  Apr 17, 16:00
34.44 +0.01 (+0.03%) Pre-Market: 20:00
More

Edgewise Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for EWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Nuvalent, Inc. --
Boston Scientific Corp. Upgrade
Edwards Lifesciences Corp. Upgrade
Eli Lilly & Co. Upgrade